Envas Injection 1 ml
₹251.1*
MRP ₹279
10% off
₹237*
MRP ₹279
15% CB
₹42 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Envas Injection 1 ml is an anti-hypertensive medicine primarily used in the treatment of Hypertension. It is used when the oral treatment is not effective. Hypertension (high blood pressure) is a serious condition in which the force exerted by the blood against the artery walls becomes high, and this hardens the heart to pump blood.
Envas Injection 1 ml contains Enalaprilat, which belongs to the class of Angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing the production of certain substances responsible for increased blood pressure.
Envas Injection 1 ml may cause certain common side effects such as cough, dizziness, headache, nausea, light-headedness, difficulty breathing, vomiting, confusion, sore throat, chest pain, abdominal pain, diarrhoea, decreased blood pressure, nervousness, injection site reactions, and hoarseness. These side effects do not require medical attention and usually resolve after some time. Envas Injection 1 ml will be administered by a trained healthcare professional. Do not self-administer.
Avoid receiving Envas Injection 1 ml and inform your doctor if you are allergic to it. Envas Injection 1 ml is contraindicated in patients with angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and hereditary or idiopathic angioedema. This medicine should be used with caution if you have/had any conditions such as congestive heart failure, liver or kidney disease, and peripheral oedema (swelling of hands/legs). It is not recommended to take this medicine during pregnancy and breastfeeding.
Envas Injection 1 ml contains Enalaprilat, which belongs to the Angiotensin-converting enzyme (ACE) inhibitors class. It works by reducing the production of certain substances that cause an increase in blood pressure. It allows the blood to flow more smoothly and makes the heart more efficient at pumping blood throughout the body. Envas Injection 1 ml helps reduce high BP and the risk of heart attack, stroke and angina (chest pain).
Avoid receiving Envas Injection 1 ml and inform your doctor if an allergic reaction occurs. Envas Injection 1 ml is contraindicated in patients with angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and hereditary or idiopathic angioedema. Envas Injection 1 ml is not recommended for use in children as the safety and efficacy are not established. On rare occasions, ACE inhibitors have been linked to a syndrome that begins with cholestatic jaundice, advances to fulminant hepatic necrosis, and occasionally results in death. When jaundice or significant elevations in hepatic enzymes occur in patients taking ACE inhibitors, the medication should be stopped, and appropriate medical attention should be given. Before receiving Envas Injection 1 ml, caution should be exercised in patients with congestive heart failure, liver disease, kidney disease, hyperkalaemia, angioedema, cough, and peripheral oedema (swelling of hands/legs). In some patients, this medicine may cause head and neck angioedema, severe anaphylactic reactions, hypotension, hepatic failure, and neutropenia. Hence, inform your doctor about your complete medication and medical history. Avoid consumption of alcohol during the treatment. If you are pregnant or breastfeeding, inform your doctor beforehand.
Drug-Drug Interactions: Envas Injection 1 ml may have interaction with heart failure medicines (sacubitril, valsartan), NSAIDs (aspirin, naproxen, indomethacin, ibuprofen), anti-gout medicines (allopurinol), anti-diabetic medicines (sitagliptin, metformin, insulin glargine), diuretics (furosemide), anti-hypertensive medication (aliskiren), potassium supplements.
Drug-Drug Interactions: Avoid consuming potassium-rich foods such as potassium-containing salt substitutes or over-the-counter potassium supplements. Avoid smoking and alcohol consumption.
Drug-Drug Interactions: Envas Injection 1 ml may have interactions with angioedema (swelling), congestive heart failure (heart problems), angioedema, low blood pressure, liver disease and kidney dysfunction.
Hypertension: Also called high blood pressure, is a serious condition in which the force exerted by the blood against the artery walls becomes high. This hardens the heart to pump blood. Raised blood pressure can cause chest pain (angina), heart attack (when the blood supply to the heart is blocked), stroke (brain damage) and kidney failure. Envas Injection 1 ml is used in treating hypertension and thus helps reduce further risk. The blood pressure can be diagnosed with the help of a blood pressure monitor called a sphygmomanometer.
Country of origin
Manufacturer/Marketer address
Alcohol
Unsafe
Do not consume alcohol while on treatment with Envas Injection 1 ml as it may worsen the side effects like dizziness and also may increase blood pressure.
Pregnancy
Unsafe
The use of Envas Injection 1 ml is contraindicated during the second and third trimester of pregnancy. It may cause harm to the developing fetus. Inform your doctor if you are pregnant before receiving Envas Injection 1 ml.
Breast Feeding
Unsafe
Envas Injection 1 ml may be excreted in human milk. Therefore, it is not recommended for breastfeeding mothers as it may be unsafe for the baby. Inform your doctor if you are breastfeeding before receiving Envas Injection 1 ml. Your doctor will decide whether you stop breastfeeding or discontinue the use of Envas Injection 1 ml based on the benefits and risks.
Driving
Caution
Envas Injection 1 ml may cause dizziness. Hence, do not drive or operate machines after receiving this medicine.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Envas Injection 1 ml. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition. Elderly patients with liver impairment should start the treatment with a lower dose.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Envas Injection 1 ml. Envas Injection 1 ml may cause renal failure in some patients. Hence, inform your doctor if the patient develops any symptoms. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition. Elderly patients with renal impairment should start the treatment with a lower dose.
Children
Unsafe
Envas Injection 1 ml is not recommended for use in children as the safety and efficacy are not established for this age group.
We provide you with authentic, trustworthy and relevant information